Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À§¾Ï¿¡¼­ Epstein-Barr Virus ¿¬°ü¼ºÀÇ ¿¹Ãø ÀÎÀÚ Predictive Factors of Epstein-Barr Virus Association in Gastric Adenocarcinoma

´ëÇѺ´¸®ÇÐȸÁö 2008³â 42±Ç 4È£ p.193 ~ 197
±è¿µ¼ö, ³²»óö, ÇѸ¸ÈÆ, Á¤ÁöÀ±, ¼­Àμö, ¹Ú¼±±Õ, ¹èÇÑÀÍ,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¿µ¼ö ( Kim Young-Su ) 
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

³²»óö ( Nam Sang-Chul ) 
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÇѸ¸ÈÆ ( Han Man-Hoon ) 
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
Á¤ÁöÀ± ( Jeong Ji-Yun ) 
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¼­Àμö ( Suh In-Soo ) 
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¹Ú¼±±Õ ( Park Sun-Kyun ) 
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¿¹¹æÀÇÇб³½Ç
¹èÇÑÀÍ ( Bae Han-Ik ) 
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract


Background: It is important to detect Epstein-Barr virus (EBV) in the setting of gastric cancer so that early viral targeted therapy and prevention can be undertaken. The aim of this study was to investigate the predictive clinicopathologic factors for EBV-related gastric cancer.

Methods: The archival tumor tissues from 335 patients with gastric cancer were examined using tissue microarray. The detection of EBV was performed using EBV mRNA in situ hybridization (EBV-ISH), and the results were compared against clinicopathologic factors.

Results: EBV-related gastric cancers were identified in 21 of 335 investigated cases (6.27%). The anatomical predisposition of EBV-related cancers to manifest in the upper stomach was statistically significant (p<0.001). EBV-related cancers were almost always (20/21) accompanied by lymphoid stroma. No differences in age, sex, histologic differentiation, or T or N stage were noted between EBV-positive and EBV-negative gastric carcinomas.

Conclusions: The association of EBV with gastric adenocarcinomas could be predicted when tumors with lymphoid stroma occurred in the upper stomach.

Å°¿öµå

Epstein-Barrvirus;Gastriccancer

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS